Medicines Optimisation (MO) Programme

About the programme

The prescription of a medicine is the most common intervention in healthcare, however over 50% of medicines are not taken as prescribed. Avoidable medication errors cost 1,700 lives and more than £98 million to the NHS in England every year. Medication errors are recognised as a global issue, with the World Health Organisation (WHO) aiming to halve the level of severe avoidable harm caused by the mistakes between 2017 and 2022.

The MO programme aims to improve the appropriate prescribing, administration, dispensing and monitoring of medicines while putting patients at the very heart of their care. The WMAHSN will seek to reduce unwarranted variation and inequalities in access to medicines and align with AHSN business priorities, strategic health goals, NHS Long-Term Plan, WHO medicines safety targets and relevant to local system deliverables.

The WMAHSN will work with all sectors in our emerging Integrated Care Systems (ICSs) to deliver a diverse set of projects which address the following areas of priority for MO in the West Midlands region:

  • Transfer of Care Around Medicines (TCAM),
  • High Risk Drugs,
  • Polypharmacy,
  • Women’s Health,
  • Antimicrobial Stewardship,
  • Environmental sustainability of medicines,
  • Integrated Pharmacy and Medicines Optimisation (IPMO).

Find out more

Click on the links below to find further information relating to specific projects under the MO programme.

  • Safer administration of medicines in care homes

    discover more
  • Prescribing opiates in non- cancer patients

    discover more
  • Pharmacy Care Home Network

    discover more
  • Transfer of Care Around Medicines To Care Homes

    discover more
  • Multicultural STOMP

    discover more
  • Asthma FeNo

    discover more
  • Asthma Biologics

    discover more
  • Environmentally sustainable medicines related waste destruction

    discover more
  • Electronic patient information leaflets

    discover more
  • Improving Anaesthetic practice using best practice toolkits

    discover more
  • Improving respiratory (Asthma and COPD) outcomes for patients and reducing the environmental impact of inhalers.

    discover more
  • Polypharmacy

    discover more
  • Development of a UTI Diagnostic Tool in Care Homes

    discover more
  • Pharmacy Environmental Sustainability Community of Practice

    discover more
Our Work